NASDAQ:RIGL

Rigel Pharmaceuticals Stock Predictions

etoro logo Buy RIGL
*Your capital is at risk
$30.30
+0.280 (+0.93%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

RIGL Prediction Chart

RIGL Predictions History

Latest community submissions for RIGL.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 28, 2025 Bullish $17.88 X 0
Skagitqg Skagitqg Merchant
Mar 3, 2025 Bullish $22.37 X 0
Jan 28, 2025 $22.31 +2.73% $22.16 V 99.31% 4
Jan 28, 2025 $21.35 -1.70% $22.16 X 96.34% 0
Skagitqg Skagitqg Merchant
Jan 28, 2025 Bearish $22.16 V 0
Dec 11, 2023 $1.29 -90.27% $1.28 V 99.28% 4
Dec 11, 2023 $1.30 -90.17% $1.28 V 98.23% 1
Dec 11, 2023 $3.00 -77.36% $1.28 X 0.00% 0
Feb 24, 2023 Bullish $1.54 X 0
Jan 23, 2023 Bullish $1.83 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RIGL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT RIGEL PHARMACEUTICALS
Rigel Pharmaceuticals
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical t...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE